[Home ]     [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 5 - The Supplement of Shefaye Khatam 2 ::
Back to browse issues page Shefaye Khatam 2017, 5 - The Supplement of Shefaye Khatam 2: 8-8
O 8: Tenasin-C as a New Target for Multiple Sclerosis Treatment
Mohammad Reza Khojasteh, Sajjad Sahab Negah *
a. Department of Neuroscience, Mashhad University of Medical Sciences, Mashhad, Iran b. Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran , Sahabsajad@yahoo.com
Abstract:   (55 Views)

Multiple Sclerosis (MS) is an autoimmune disease, which is characterized by demyelination and neuroinflammation. Extracellular Matrix (ECM) have important role in the central nervous system (CNS). Alterations are happening to the ECM after the CNS disorder like MS, Alzheimer and other neural injury. Tenasin-C (TnC) is a glycoprotein that is highly expressed in inflammatory conditions of the CNS and expression of this protein is up regulated in tissues and organs that are affected by inflammation. Currently cell therapy is one of the main hopes for MS treatment. Unfortunately there is no powerful study to examine the correlation between the Cell Therapy and expression of TnC as a dependent variable for investigates of the improvement percent. Transplantation of mesenchymal stem cells to the experimental autoimmune encephalomyelitis (EAE) model and investigate quantity of the TnC before and after cell transplantation. Evaluation of TnC in the experimental autoimmune encephalomyelitis (EAE) model after mesenchymal stem cells transplantation may be useful for MS treatment. 

Keywords: Tenasin-C, Multiple sclerosis, Mesenchymal stem cell
Full-Text [PDF 230 kb]   (21 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khojasteh M R, Sahab Negah S. O 8: Tenasin-C as a New Target for Multiple Sclerosis Treatment. Shefaye Khatam. 2017; 5 (S2) :8-8
URL: http://shefayekhatam.ir/article-1-1162-en.html
Back to browse issues page Volume 5 - The Supplement of Shefaye Khatam 2
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.049 seconds with 785 queries by yektaweb 3345